European Archives - Page 928 of 982 - European Medical Journal

EMJ

Prof Kenneth Anderson chairs a discussion on novel immunotherapies for treating multiple myeloma

At the Myeloma 2015 meeting, Prof Kenneth Anderson (Harvard Medical School, Boston, MA) chairs a discussion with Prof Jesús San Miguel (University of…

Dr Keith Stewart chairs a discussion on tumour biology-guided treatment for multiple myeloma

At the Myeloma 2015 meeting, Dr Keith Stewart (Mayo Clinic, Scottsdale, AZ) chairs a discussion with Prof Gareth Morgan (University of Arkansas…

Clinical significance of progenitor cells in multiple myeloma

Prof Kenneth Anderson (Harvard Medical School, Boston, MA) chairs a discussion with Prof Leif Bergsagel (Mayo Clinic, Scottsdale, AZ) and Prof Gareth…

EMJ

An update on the Multidisciplinary Application of Genomics in Clinical Practice (MAGIC) survey

At the 14th St. Gallen International Breast Cancer Conference 2015, Dr Matti Aapro (Clinique de Genolier, Genolier, Switzerland) discusses the design…

EMJ

PALOMA-1 study of palbociclib in ER+, HER2-, breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Dr Véronique Diéras (Institut Curie, Paris, France) discusses the phase 2 PALOMA-1…

EMJ

The importance of the St. Gallen Breast Cancer Conference

Dr Clifford Hudis (Memorial Sloan Kettering Cancer Center, New York, NY) discusses the opportunities at the 14th St. Gallen International Breast Cancer…

A New Approach for the Patient with Erectile Dysfunction

This satellite symposium was held in two sessions. The first session was offered in a traditional format where invited experts reviewed and discussed the…

Navigating the mCRPC Landscape: Exploring Key Clinical Decision Points

The Bayer satellite symposium was introduced by Prof Fred Saad, who gave an introduction into the use of radium-223 in metastatic castration-resistant…

Pushing the Limits with Nanoknife®: A Promising New Technology in Localised Prostate Cancer Management

In the last few decades, the ever-increasing improvements in cancer detection have allowed urologists to detect prostate cancer (PrC) at earlier stages…

Chemotherapy and New Drugs in Prostate Cancer

Prostate cancer (PrC) is the fourth most common cancer (for both sexes combined) and the second most common cancer in men (accounting for 15% of all new…